Cancer clinical trials in the region Bourgogne-Franche-Comté

213 currently recruiting clinical trials

Looking for clinical trials?

Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:

Create your account
Copy-paste your latest medical report
Our AI-based assistant does the rest for you

Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:

Create your account

Phase 1 / Phase 2 Lung cancer #NCT06162221

Étude des combinaisons d'inhibiteurs du RAS(ON) chez les patients atteints d'un CBNPC avancé muté par le RAS - Sous étude D

NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic KRAS G12D 1 2 3 or more

Systemic Treatment-Naive Systemic Treatment-Naive

14 recruiting sites

Revolution Medicines, Inc.

Phase 1 / Phase 2 Lung cancer #NCT06710132

[PROCEADE PanTumor ] Étude de l'ADC M9140 anti-CEACAM5 chez des participants atteints de tumeurs solides avancées - Sous-étude CBNPC

NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic 1 2 3 or more Chemotherapy Targeted therapy

Systemic Treatment-Naive

8 recruiting sites

EMD Serono Research & Development Institute, Inc.

Phase 1 / Phase 2 Pancreas cancer #NCT06710132

[PROCEADE PanTumor ] Étude de l'ADC M9140 anti-CEACAM5 chez des participants atteints de tumeurs solides avancées - Sous-étude PDAC

Adenocarcinoma Locally Advanced Metastatic 1 2 Chemotherapy

Systemic Treatment-Naive

8 recruiting sites

EMD Serono Research & Development Institute, Inc.

Phase 1 / Phase 2 Colon cancer Rectal cancer Anal cancer Pancreas cancer #NCT06162221

Étude des combinaisons d'inhibiteurs du RAS(ON) chez les patients atteints d'une tumeur maligne solide avancée mutée par le RAS - Sous étude A

Locally Advanced Metastatic KRAS G12C 1 2 3 or more

Systemic Treatment-Naive Systemic Treatment-Naive

14 recruiting sites

Revolution Medicines, Inc.

Phase 1 / Phase 2 Stomach and esophageal cancer #NCT06710132

[PROCEADE PanTumor ] Étude de l'ADC M9140 anti-CEACAM5 chez des participants atteints de tumeurs solides avancées - Sous-étude GC

Stomach Oesogastric junction Adenocarcinoma Locally Advanced Metastatic 1 2 Chemotherapy

HER2 Systemic Treatment-Naive

8 recruiting sites

EMD Serono Research & Development Institute, Inc.

Not Applicable Thymus cancer #NCT04731610

[RADIO-RYTHMIC-01] Essai randomisé, multicentrique, de phase III visant à évaluer la radiothérapie postopératoire conformationnelle par rapport à la surveillance après résection complète d'un thymome de stade II/III

Thymoma Localized Surgery

14 recruiting sites

Institut Curie

Not Applicable Lung cancer #NCT03117946

Modulation des réponses des lymphocytes T antitumoraux chez les patients atteints de cancer traités par radiochimiothérapie concomitante

SCLC (Small Cell Lung Cancer) NSCLC (Non-Small Cell Lung Cancer) Localized None Systemic Treatment-Naive

Immunotherapy Chemotherapy Radiotherapy

4 recruiting sites

Centre Hospitalier Universitaire de Besancon

Not Applicable Lung cancer #NCT06053099

[ROSIE] Étude de cohorte prospective visant à évaluer les facteurs pronostiques moléculaires et les mécanismes de résistance à l'osimertinib dans le traitement adjuvant du carcinome pulmonaire non à petites cellules pIB-IIIA complètement réséqué présentant des mutations EGFR courantes (L858R et Del19)

Single Cohort

NSCLC (Non-Small Cell Lung Cancer) Localized EGFR None Systemic Treatment-Naive Surgery

37 recruiting sites

Intergroupe Francophone de Cancérologie Thoracique

Not Applicable Pancreas cancer Stomach and esophageal cancer #NCT05443087

[TARGETMONITO] Suivi ciblé des médicaments thérapeutiques en oncologie digestive - Cohorte 2

Neuroendocrine tumor Locally Advanced Metastatic None Systemic Treatment-Naive

18 recruiting sites

UNICANCER

Not Applicable Pancreas cancer #NCT05443087

[TARGETMONITO] Suivi ciblé des médicaments thérapeutiques en oncologie digestive - Cohorte 3

Neuroendocrine tumor Locally Advanced Metastatic None Systemic Treatment-Naive

18 recruiting sites

UNICANCER